Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 77518

7 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
June 01, 2017
Product types
Device
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Shippert Medical Technologies

Dossier provenance

Source snapshots represented here

  • openFDA Device Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
  • openFDA Device Recall event_date_initiated coverage June 01, 1997–June 30, 2026

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

7 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

device · product 1 of 7

Tissu-Trans Filtron 100, 3-TT-FILTRON 100. Product Usage: Intended for fat transfer and liposuction.

Z-3060-2017
Recall number
Z-3060-2017
Initiated
June 01, 2017
Classification
Class II
Status
Terminated
Quantity
5,188 units total

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Seal integrity of the Tissu-Trans product sterile packages cannot be assured.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Packaging

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Seal integrity of the Tissu-Trans product sterile packages cannot be assured.

Code information

Lot Numbers 12018, 12045, 12076, 12109.

Distribution pattern

Worldwide Distribution - US Nationwide in the states of: AL, AR, AZ, CA, CO, CT, FL, GA, HI, IL, IN, KS, KY, MD, MI, MN, MO, NC, NJ, NV, NY, OH, OR, PA, TN, TX, UT, VA, WA, WV. and the countries of: Italy, Austria, Turkey, United Arab Emirates, Germany, Spain, Saudi Arabia, Switzerland, Japan Kuwait, Denmark, Sweden, United Kingdom, Belgium, France, Australia, Netherlands, Greece, South Korea.

device · product 2 of 7

Tissu-Trans Filtron 250, 3-TT-FILTRON 250. Product Usage: Intended for fat transfer and liposuction.

Z-3061-2017
Recall number
Z-3061-2017
Initiated
June 01, 2017
Classification
Class II
Status
Terminated
Quantity
5,188 units total

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Seal integrity of the Tissu-Trans product sterile packages cannot be assured.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Packaging

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Seal integrity of the Tissu-Trans product sterile packages cannot be assured.

Code information

Lot Numbers 12005, 12019, 12044, 61286, 61421.

Distribution pattern

Worldwide Distribution - US Nationwide in the states of: AL, AR, AZ, CA, CO, CT, FL, GA, HI, IL, IN, KS, KY, MD, MI, MN, MO, NC, NJ, NV, NY, OH, OR, PA, TN, TX, UT, VA, WA, WV. and the countries of: Italy, Austria, Turkey, United Arab Emirates, Germany, Spain, Saudi Arabia, Switzerland, Japan Kuwait, Denmark, Sweden, United Kingdom, Belgium, France, Australia, Netherlands, Greece, South Korea.

device · product 3 of 7

Tissu-Trans Filtron 500, 3-TT-FILTRON 500. Product Usage: Intended for fat transfer and liposuction.

Z-3062-2017
Recall number
Z-3062-2017
Initiated
June 01, 2017
Classification
Class II
Status
Terminated
Quantity
5,188 units total

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Seal integrity of the Tissu-Trans product sterile packages cannot be assured.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Packaging

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Seal integrity of the Tissu-Trans product sterile packages cannot be assured.

Code information

Lot Numbers 11934, 11948, 11984, 12002, 12020, 12046, 61119, 61287, 61363, 61146.

Distribution pattern

Worldwide Distribution - US Nationwide in the states of: AL, AR, AZ, CA, CO, CT, FL, GA, HI, IL, IN, KS, KY, MD, MI, MN, MO, NC, NJ, NV, NY, OH, OR, PA, TN, TX, UT, VA, WA, WV. and the countries of: Italy, Austria, Turkey, United Arab Emirates, Germany, Spain, Saudi Arabia, Switzerland, Japan Kuwait, Denmark, Sweden, United Kingdom, Belgium, France, Australia, Netherlands, Greece, South Korea.

device · product 4 of 7

Tissu-Trans Filtron 1000, 3-TT-FILTRON 1000. Product Usage: Intended for fat transfer and liposuction.

Z-3063-2017
Recall number
Z-3063-2017
Initiated
June 01, 2017
Classification
Class II
Status
Terminated
Quantity
5,188 units total

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Seal integrity of the Tissu-Trans product sterile packages cannot be assured.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Packaging

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Seal integrity of the Tissu-Trans product sterile packages cannot be assured.

Code information

Lot Numbers 12047, 12077, 61235.

Distribution pattern

Worldwide Distribution - US Nationwide in the states of: AL, AR, AZ, CA, CO, CT, FL, GA, HI, IL, IN, KS, KY, MD, MI, MN, MO, NC, NJ, NV, NY, OH, OR, PA, TN, TX, UT, VA, WA, WV. and the countries of: Italy, Austria, Turkey, United Arab Emirates, Germany, Spain, Saudi Arabia, Switzerland, Japan Kuwait, Denmark, Sweden, United Kingdom, Belgium, France, Australia, Netherlands, Greece, South Korea.

device · product 5 of 7

Tissu-Trans Filtron 2000, 3-TT-FILTRON 2000. Product Usage: Intended for fat transfer and liposuction.

Z-3064-2017
Recall number
Z-3064-2017
Initiated
June 01, 2017
Classification
Class II
Status
Terminated
Quantity
5,188 units total

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Seal integrity of the Tissu-Trans product sterile packages cannot be assured.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Packaging

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Seal integrity of the Tissu-Trans product sterile packages cannot be assured.

Code information

Lot Numbers 11947, 12003, 12078, 12110.

Distribution pattern

Worldwide Distribution - US Nationwide in the states of: AL, AR, AZ, CA, CO, CT, FL, GA, HI, IL, IN, KS, KY, MD, MI, MN, MO, NC, NJ, NV, NY, OH, OR, PA, TN, TX, UT, VA, WA, WV. and the countries of: Italy, Austria, Turkey, United Arab Emirates, Germany, Spain, Saudi Arabia, Switzerland, Japan Kuwait, Denmark, Sweden, United Kingdom, Belgium, France, Australia, Netherlands, Greece, South Korea.

device · product 6 of 7

Tissu-Trans MEGA 1500, 3-TT-MEGA 1500. Product Usage: Intended for fat transfer and liposuction.

Z-3065-2017
Recall number
Z-3065-2017
Initiated
June 01, 2017
Classification
Class II
Status
Terminated
Quantity
5,188 units total

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Seal integrity of the Tissu-Trans product sterile packages cannot be assured.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Packaging

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Seal integrity of the Tissu-Trans product sterile packages cannot be assured.

Code information

Lot Numbers 12082, 12111, 61116, 61236, 61288, 61364, 61464.

Distribution pattern

Worldwide Distribution - US Nationwide in the states of: AL, AR, AZ, CA, CO, CT, FL, GA, HI, IL, IN, KS, KY, MD, MI, MN, MO, NC, NJ, NV, NY, OH, OR, PA, TN, TX, UT, VA, WA, WV. and the countries of: Italy, Austria, Turkey, United Arab Emirates, Germany, Spain, Saudi Arabia, Switzerland, Japan Kuwait, Denmark, Sweden, United Kingdom, Belgium, France, Australia, Netherlands, Greece, South Korea.

device · product 7 of 7

Tissu-Trans SFILL 360, 3-TT-SFILL 360. Product Usage: Intended for fat transfer and liposuction.

Z-3066-2017
Recall number
Z-3066-2017
Initiated
June 01, 2017
Classification
Class II
Status
Terminated
Quantity
5,188 units total

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Seal integrity of the Tissu-Trans product sterile packages cannot be assured.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Packaging

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Seal integrity of the Tissu-Trans product sterile packages cannot be assured.

Code information

Lot Numbers 12079, 61117, 61143, 61405.

Distribution pattern

Worldwide Distribution - US Nationwide in the states of: AL, AR, AZ, CA, CO, CT, FL, GA, HI, IL, IN, KS, KY, MD, MI, MN, MO, NC, NJ, NV, NY, OH, OR, PA, TN, TX, UT, VA, WA, WV. and the countries of: Italy, Austria, Turkey, United Arab Emirates, Germany, Spain, Saudi Arabia, Switzerland, Japan Kuwait, Denmark, Sweden, United Kingdom, Belgium, France, Australia, Netherlands, Greece, South Korea.